L-methionine (Met) has been implicated in parenteral nutrition-associated cholestasis in infants and, at high levels, causes liver toxicity by mechanisms that are not clear. In this study, Met toxicity was characterized in freshly-isolated male and female mouse hepatocytes incubated with 5-30 mM Met for 0 to 5 h. In male hepatocytes, 20 mM Met was cytotoxic at 4 h as indicated by trypan blue exclusion and LDH leakage assays. Cytotoxicity was preceded by GSH depletion at 3 h without GSSG formation.
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Introduction L-Methionine (Met), while necessary for life, is also regarded as the most toxic amino acid of those normally involved in protein synthesis (Benevanga, 1974) . Rats given excessive dietary Met had increased markers of lipid peroxidation in the liver after six months (Mori and Hirayama, 2000) . Guinea pigs injected with toxic levels of Met developed fatty liver with hepatocytic ATP depletion, nucleolar disaggregation, and RNA synthesis inhibition (Shinozuka et al., 1971; Cox et al., 1973) . Rabbits infused with Met alone or with the Met-containing total parenteral nutrition (TPN) solution given to infants developed nearly identical choleostatic liver damage indicating that Met toxicity may contribute to TPN cholestasis in infants (Moss et al., 1999) . Additionally, male Met adenosyltransferase 1A (MAT1A) knockout mice exhibited an 8-fold elevation of plasma Met levels associated with an increased sensitivity to oxidative stress and liver injury in comparison with wild-type littermates (Lu et al., 2001 ).
Many studies have provided insights into the potential mechanisms of Metinduced liver toxicity. Several metabolites from the Met transmethylation (TM) pathway have been studied for their toxicological contributions (Figure 1 ). Met TM begins with the ATP-dependent conversion of Met to S-adenosylmethionine (SAM), an important biological methyl donor molecule (Finkelstein, 1990) . ATP depletion from excessive SAM formation as well as the accumulation of SAM itself have been linked to Metinduced hepatotoxicity, however the evidence is largely correlative (Hardwick et al., 1970; Regina et al., 1993) . Methyl group donation from SAM results in the formation of S-adenosylhomocysteine (SAH) which is subsequently hydrolyzed to homocysteine (Hcy) (Finkelstein, 1990) . Elevated levels of Hcy, which may be converted to the lysineThis article has not been copyedited and formatted. The final version may differ from this version.
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jpet.aspetjournals.org Downloaded from JPET #141044 5 reactive metabolite Hcy thiolactone, have been clearly linked to arteriosclerosis and are an independent risk factor for cardiovascular disease in humans (Chwatko and Jakubowski, 2005) . The toxicological role of Hcy and/or Hcy thiolactone in Met-induced liver toxicity, however, has not been investigated.
Alternative to Met TM, the Met transamination (TA) pathway has also been investigated for its involvement in Met toxicity (Figure 1 ). Met TA is catalyzed by multiple transaminases including glutamine transaminase K and L and results in the formation of 2-keto-4-methylthiobutyric acid (KMB) (Cooper, 1989; Scislowski and Pickard, 1993) . KMB is then oxidatively decarboxylated by branched chain 2-oxo acid dehydrogenase complex to form 3-methylthiopropionic acid (3-MTP) (Steele and Benevenga, 1978; Jones and Yeaman, 1986) . 3-MTP is further metabolized to the highly toxic and volatile molecules methanethiol, hydrogen sulfide and dimethylsulfide Blom et al., 1988a; Gahl et al., 1988; Tangermen et al., 2000) .
Methanethiol has been shown to inhibit enzymes involved in protection from peroxidative damage in a similar fashion to Met (Finkelstein and Benevenga, 1986) .
Furthermore, rats fed 3-MTP-spiked chow exhibited markedly similar toxicological symptoms as rats fed chow spiked with excess Met which included growth retardation and hemolytic anemia . Taken together, these studies suggest that Met TA may also be involved in Met-induced liver toxicity.
In summary, the Met TM and TA pathways have both been implicated as toxicologically relevant pathways, but their relative roles in the liver toxicity associated with hypermethionemia remain unclear. The primary purpose of this study was to assess and compare the relative toxicological roles of Met TM and TA in freshly-isolated male This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on June 13, 2008 as DOI: 10.1124 at ASPET Journals on January 8, 2018 jpet.aspetjournals.org Downloaded from JPET #141044 6 or female mouse hepatocytes exposed to high levels of Met through the use of inhibitors of these pathways. Met TA was inhibited using 0.2 mM aminooxyacetic acid (AOAA) which was previously shown to inhibit Met TA in vitro (Mitchell and Benevenga, 1978) .
The formation of the Met TM metabolites Hcy and Hcy thiolactone was inhibited using 0.1 mM 3-deazaadenosine (3-DA), a known inhibitor of SAH hydrolase (GarciaTrevijano et al., 2000) . Trypan blue exclusion, LDH leakage, GSH and GSSG levels, and Caspase 3/7 activation were measured to characterize and quantitate the Met-induced cytotoxic and biochemical effects. The toxicity of D-methionine (D-Met) and 3-MTP was also characterized using these endpoints to gain further insight into the mechanism of Met-induced toxicity.
This article has not been copyedited and formatted. The final version may differ from this version. Medium (DMEM) (1x) with 4500 mg/L glucose, and sodium pyruvate but without Lglutamine, methionine, and cystine was purchased from HyClone (Logan, UT). All other chemicals and reagents were of the highest quality commercially available.
Animals.
Male and female B6C3F1 mice (7-11 weeks old) were purchased from Jackson Laboratories (Bar Harbor, ME). Mice were maintained on a 12-h light/dark cycle and were allowed feed and water ad libitum. Hepatocytes were isolated at the same time of day to minimize the effects of circadian variation on GSH levels and other enzymatic processes of interest. Hepatocytes were isolated using the two-step EDTA / collagenase perfusion method as described by Kemper et al. (2000) except that livers were perfused with 0.6 mg / mL collagenase solution. The collagenase solution was also centrifuged at 39000 g for 30 min to remove non-soluble components. Initial cell yield and viability were determined by trypan blue exclusion using a hemacytometer. Only hepatocytes with an initial overall viability of greater than 85% after isolation were used in This article has not been copyedited and formatted. The final version may differ from this version. Measurement of apoptosis. Apoptosis was measured using the Caspase-Glo 3/7 luminescence assay as described by Promega (Madison, WI) . Briefly, 50 µ L Caspase 3/7 reagent was added to 50 µ L of cell sample. The reaction was allowed to proceed at room temperature for 30 min before luminescence was measured. Background luminescence from the medium in each sample was also measured and subtracted from the value obtained with cells in medium to obtain the final corrected value. Dimethyl sulphoxide (5% solution) was used as a positive control.
Quantitation of GSH and GSSG. Samples were obtained to measure intracellular and medium levels of GSH and GSSG. Briefly, 500 µL of cell sample was centrifuged at 50 g for 2 min. An aliquot of the supernatant (200 µL) was then added to 800 µL of 5%
SSA to be used for analysis of GSH and GSSG levels in the medium. The cell pellet was then washed with 1 mL of phosphate-buffered saline, pH=7.4. Following centrifugation at 50 g for 2 min, the supernatant was removed from the pellet and 1.25 mL of 5% SSA was added. The resulting solution was transferred to a clean microcentrifuge tube and stored at -80ºC until analysis. GSH and GSSG levels were measured using the enzymatic recycling method of Tietze (1969) . All samples were first centrifuged at 10000 g for 5 min. "Total GSH" (GSH+GSSG) levels and GSSG levels alone were then determined as described by Gunnarsdottir and Elfarra (2003) . Standard curves were run in all experiments to allow for quantitation of the results. The concentration of reduced GSH in a sample was determined by subtracting the molar amount of GSH equivalents coming from GSSG from the molar amount of total GSH calculated from the standard curve.
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Results
To characterize the toxicity of Met in freshly-isolated male and female mouse hepatocytes, cell viability along with cellular and medium GSH/GSSG levels were monitored in hepatocytes exposed to medium alone or medium containing increasing concentrations of Met for 0-5 h at 37ºC.
Male hepatocytes exposed to 30 mM Met had decreased cell viability as determined by trypan blue exclusion ( Figure 2A ) and LDH leakage ( Figure 2C ) starting at 3 h compared to hepatocytes exposed to medium alone. Additionally, Met-exposed male hepatocytes had depleted intracellular GSH levels starting at 2 h compared to hepatocytes incubated in medium alone ( Figure 3A ). Incubations with 30 mM D-Met resulted in no cytotoxicity or GSH depletion (Figure 4) . Exposure of male hepatocytes to 20 mM Met led to GSH depletion by 3 h ( Figure 3A ) and cytotoxicity at 4 h ( Figure 2A and 2C) indicating a dose-dependent response. Incubations with 5 and 10 mM Met resulted in no detectable cytotoxicity. No caspase 3/7 activation was detected at any time point or Met concentration. Interestingly, female hepatocytes exposed to 30 mM Met showed no cytotoxic effects ( Figure 2B and 2D) and significantly higher GSH levels at 2 and 3 h ( Figure 3B ) compared to hepatocytes exposed to medium alone. Medium GSH levels in Met-exposed male and female hepatocytes were lower than hepatocytes exposed to medium alone starting at 2 and 3 h, respectively ( Figure 3C and 3D ). Cellular and medium GSSG levels in Met-exposed hepatocytes of both genders were similar to or lower than levels in hepatocytes exposed to medium alone (data not shown).
To assess the role of Met TA in Met toxicity in male mouse hepatocytes, the effect of the transaminase inhibitor AOAA was tested. Addition of 0.2 mM AOAA This article has not been copyedited and formatted. The final version may differ from this version. ameliorated Met-induced GSH depletion compared to cells exposed to 30 mM Met alone ( Figure 5A ). Moreover, AOAA protected male hepatocytes from Met-induced cytotoxicity at 3, 4, and 5 h leading to a nearly two-fold increase in cell viability at each of these time points compared to cells exposed to only 30 mM Met ( Figure 6A and 6C).
To assess the role of Met TM and homocysteine formation in Met toxicity in male mouse hepatocytes, the effect of the inhibitor 3-DA was examined. In contrast to AOAA, addition of 0.1 mM 3-DA to Met-exposed cells seemed to increase the magnitude of GSH depletion compared to hepatocytes exposed to Met alone at 2 h ( Figure 5B ), though the results were not statistically significant (p=0.12). 3-DA also potentiated Met-induced cytotoxicity resulting in a significant decrease in cell viability starting at 2 h ( Figure 6B and 6D). At 3 h and 4 h, the viability of cells exposed to 30 mM Met and 0.1 mM 3-DA was nearly half that of cells exposed to Met alone.
Since the above studies indicated that Met TA was an important pathway for Met toxicity, the toxicity of 3-MTP, a known human Met TA metabolite, was investigated.
Exposure of male hepatocytes to 0.3 mM 3-MTP resulted in toxicity that was similar in profile to that of 30 mM Met including trypan blue and LDH cytotoxicity starting at 3 h ( Figure 7A and 7C respectively) preceded by GSH depletion starting at 2 h ( Figure 7E) without concomitant GSSG formation (data not shown). The toxicity of 3-MTP was also assessed in female hepatocytes to further investigate potential mechanisms responsible for the gender-dependent toxicity of Met. Exposure of female hepatocytes to 0.3 mM 3-MTP resulted in GSH depletion at 3 h ( Figure 7F ), but little to no cytotoxicity ( Figure 7B and 7D).
This article has not been copyedited and formatted. The final version may differ from this version. The Met-induced depletion of GSH without GSSG formation in male hepatocytes suggested that GSH was conjugating with reactive metabolites. Thus, Met TA may be involved in the production of GSH-reactive electrophiles. Further metabolism of 3-MTP has been investigated by Blom et al. (1988a) 14 and rat hepatocytes. Gahl et al. (1988) also detected increased levels of mixed disulfides (CH 3 S-SX) in a human with hepatic MAT deficiency. Thus, it is likely that volatile sulfur molecules formed in the Met TA pathway react with free GSH to form mixed GSH disulfides. The excessive formation of both protein and non-protein mixed disulfides in the cell may result in cellular damage and cytotoxicity.
The potentiation of Met toxicity by 3-DA indicated that formation of Hcy via the Met TM pathway did not play a major role in Met hepatotoxicity and suggested that Met TM acted as a detoxification pathway at these Met levels. Exposure to 3-DA is known to result in increased SAM and SAH levels and inhibition of methylation reactions in liver (Duerre, 1988; Prytz and Aarbakke, 1990) . The buildup of SAM results in feedback inhibition of MAT activity (Finkelstein, 1990) . Thus, more Met may be available for Met TA which may explain the increased hepatotoxicity detected in this study. It cannot be ruled out, however, that a toxic buildup of cellular SAM or SAH also played a role in the potentiation of Met hepatotoxicity by 3-DA.
The finding that female hepatocytes were completely resistant to Met hepatotoxicity and had higher cellular GSH levels after Met exposure was interesting and unexpected. Increases in cellular GSH levels in Met-exposed female hepatocytes may be due to increased GSH synthesis via cysteine formation from the Met TM pathway (Wang et al., 1997) . Met has also been shown to inhibit cellular GSH efflux by 50-70% in Metexposed rat hepatocytes, possibly by allosteric inhibition of the GSH transport system, resulting in higher cellular GSH levels compared to control cells (Aw et al., 1986) .
Consistent with this finding, we detected lower medium and higher cellular GSH levels at JPET #141044 15 alone. While similar processes may occur in male hepatocytes, any cellular gains in GSH levels appear to be overwhelmed by GSH losses secondary to Met TA and formation of mixed disulfides.
Gender differences in 3-MTP toxicological sensitivity allowed for some insights to be gained regarding potential mechanisms of gender-dependent Met hepatotoxicity.
Female hepatocytes were much less sensitive to 3-MTP-induced cytotoxicity compared to male hepatocytes, but were only slightly less sensitive to 3-MTP-induced GSH depletion.
These results suggest that cellular events independent of GSH depletion may play a role in gender differences in 3-MTP and Met cytotoxicity. Other mechanisms may also be involved in eliciting gender dependent Met hepatotoxicity and GSH depletion. For example, male and female differences in cellular Met uptake and efflux could result in sensitivity differences to Met hepatotoxicity. Met is known to be transported by both the "A" and "L" amino acid transport systems. Hissin and Hilf (1979) reported that 17β-estradiol inhibited system "A" transport of proline in vitro in breast cancer cells demonstrating that sex-hormones can modulate amino acid transport systems utilized by Met. While the effect of 17β-estradiol on liver amino acid transport is not known, lower levels of Met uptake in female hepatocytes compared to males could contribute to their resistance to Met hepatotoxicity. Gender differences in Met metabolism such as increased Met TM and/or decreased Met TA in females could also contribute to the observed toxicological differences. In support of this hypothesis, Met-dosed female mice had higher levels of SAM present in the liver after 15 min compared to Met-dosed males (Dever and Elfarra, 2006) . Further investigations are required to examine potential This article has not been copyedited and formatted. The final version may differ from this version.
jpet.aspetjournals.org Downloaded from gender differences in 3-MTP metabolism and rates of Met TM and Met TA in mouse hepatocytes.
While gender differences in Met hepatotoxicity have not been previously reported, interspecies differences were identified by Shinozuka et al. (1971) who found that guinea pigs were more sensitive than rats to Met-induced liver toxicity after i.p.
injection of a single high dose of Met. Interestingly, however, guinea pigs of both sexes were used while in rats, only females were dosed. Our finding that female mouse hepatocytes were resistant to Met hepatotoxicity complicates the conclusions of that study since male rats were not tested and it is unknown whether rats would also exhibit gender-dependent toxicity following exposure to excess Met.
In humans, the toxicological significance of the Met TA pathway remains unclear.
Typical Met levels in hypermethionemic humans (0.5-2.5 mM) are significantly lower than the concentrations of Met required to elicit cytotoxicity in mouse hepatocytes in the present study (20 mM) suggesting that they may not be sufficient to cause liver injury (Gahl et al., 1988; Chou, 2000) . However, Met toxicity has been implicated in TPNcholestasis, a condition characterized by liver damage and high plasma Met levels (1-1.5 mM) in infants as well as decreased hepatic GSH levels in neonatal rats (Heyman et al., 1984; Moss et al., 1999) . Furthermore, the Met TM pathway has been shown to be immature and not fully functional in infants (Balistreri et al., 1983) . Taken together, these observations suggest that Met TA could play a toxicological role in TPNcholestasis.
Gender differences in Met metabolism in humans have also been reported. Higher levels of Met transamination products were detected in premenopausal women given oral This article has not been copyedited and formatted. The final version may differ from this version. 17 Met compared to men of similar age given oral Met (Blom et al., 1988b) . It was suggested that increased Met TA in healthy humans may actually function as a protective pathway by preventing formation of Hcy and decreasing the long-term cardiovascular risk correlated with high levels of Hcy.
In conclusion, male freshly-isolated mouse hepatocytes, but not female, exhibited GSH depletion followed by cytotoxicity when exposed to high levels of Met. The This article has not been copyedited and formatted. The final version may differ from this version.
